The global Capsule Endoscopy Market is on a strong growth path as healthcare providers and patients increasingly favor minimally invasive diagnostic options, according to Kings Research. The market was valued at USD 398.8 million in 2023 and is estimated at USD 426.4 million in 2024. It is projected to reach USD 713.4 million by 2031, expanding at a compound annual growth rate (CAGR) of 7.63% from 2024 to 2031. A rising burden of gastrointestinal disease, rapid technological progress, and the arrival of remote and home-based procedures are shaping the industry’s next phase.
Market Overview
Capsule endoscopy is a medical procedure used to visually examine the digestive tract, particularly the small intestine, with a small swallowable capsule containing a camera. The capsule transmits images to an external recorder, allowing physicians to diagnose conditions such as Crohn’s disease and gastrointestinal bleeding, which can be difficult to detect using conventional endoscopic procedures. The main types include small bowel, esophageal, and colon capsule endoscopy.
The market is expanding rapidly because patients and providers are prioritizing safer, more comfortable, and non-invasive alternatives to traditional diagnostic techniques. Capsule endoscopy allows visualization of the gastrointestinal tract without incisions, which is driving adoption across hospitals, clinics, and diagnostic centers. The shift toward non-invasive technologies continues to be a central force behind growth.
Real-world deployments show how access is widening. In November 2024, Guam Regional Medical City introduced an advanced capsule endoscopy service backed by a USDA Rural Development grant. The service offers a minimally invasive solution for digestive health diagnostics and integrates remote telemedicine, extending specialist care to a more remote population.
Key Highlights from the Report
North America held a market share of 33.75% in 2023, valued at USD 134.6 million. The small bowel capsule endoscopy segment generated USD 137.3 million in revenue in 2023. The obscure gastrointestinal bleeding (OGIB) application is expected to reach USD 264.1 million by 2031. Diagnostic laboratories are anticipated to register the fastest CAGR among end users at 7.75%, and Asia Pacific is expected to grow at a CAGR of 8.50% during the forecast period.
Market Driver: Rising Incidence of Gastrointestinal Disorders
The growing prevalence of conditions such as Crohn’s disease, colorectal cancer, and gastrointestinal bleeding is significantly increasing demand for advanced diagnostic tools. According to the National Center for Health Statistics, 8.4 million emergency department visits in 2023 had a disease of the digestive system as the primary diagnosis.
These conditions often call for early detection and precise imaging to guide effective treatment. Capsule endoscopy offers an efficient, non-invasive alternative to procedures such as colonoscopy, providing detailed images of the digestive tract. Providers are adopting it to improve patient care, diagnostic confidence, and treatment outcomes.
Regulatory milestones are supporting this adoption. In May 2024, the U.S. Food and Drug Administration cleared the next-generation Medtronic PillCam solution suite, which delivers improved imaging and a more efficient, patient-friendly approach to gastrointestinal health.
Market Challenge: Risk of Capsule Retention
A rare but important challenge is capsule retention, where the device remains in the gastrointestinal tract and may cause complications. Although uncommon, it requires careful monitoring and shapes clinician caution in some patient groups.
The industry is responding with design and process improvements. Dissolvable or more compact capsules, real-time tracking technologies, improved patient screening, and structured post-procedure follow-up can all reduce retention risk and help ensure safer outcomes. Continued progress in these areas should strengthen clinician and patient confidence.
Market Trend: Home-Based Diagnostics
A notable trend is the rise of home-based diagnostics. Advances in home-use technology now allow patients to undergo capsule endoscopy from the comfort of their own homes. This improves accessibility, reduces hospital visits, and increases patient convenience. Telemedicine integration and remote monitoring allow healthcare providers to review results in real time, supporting accurate diagnosis and personalized care.
In December 2024, Medtronic announced the first successful ingestion of its next-generation PillCam Genius SB Kit at the University of Miami Health System. The kit allows procedures to be performed either in clinical settings or remotely during telehealth appointments, improving access and convenience for both patients and clinicians.
Segmentation Analysis
The report segments the market by type, application, end user, and region. By type, the small bowel capsule endoscopy segment earned USD 137.3 million in 2023, reflecting its effectiveness in diagnosing small intestine disorders. Esophageal and colon capsule endoscopy, along with other types, complete the segmentation.
By application, the market includes OGIB, Crohn’s disease, small intestine tumors, and others. The OGIB segment held a 37.37% share in 2023, driven by demand for accurate bleeding detection and diagnosis.
By end user, the market covers hospitals, diagnostic laboratories, and specialty clinics. Hospitals are projected to reach USD 266.4 million by 2031, owing to growing patient volumes and advanced diagnostic technologies, while diagnostic laboratories are expected to grow at the fastest pace.
Regional Analysis
North America accounted for a 33.75% share in 2023, valued at USD 134.6 million, making it the leading region. Advanced healthcare infrastructure, high patient awareness, and strong demand for non-invasive diagnostic solutions underpin its position. The United States is a key contributor, with rising gastrointestinal disease cases and rapid uptake of innovative technologies. Extensive research and development by leading healthcare companies and academic institutions continues to drive progress. In July 2024, research at the Children’s Health Orange County research institute, with collaborators from UCI Medical Center and Chapman University, explored AI and diagnostic imaging to predict pediatric inflammatory bowel disease outcomes, an effort aligned with advances in non-invasive gastrointestinal diagnostics.
Asia Pacific is the fastest-growing region, with a projected CAGR of 8.50% and a forecast market value of USD 166.7 million in 2031. Increasing prevalence of gastrointestinal disease, improving healthcare infrastructure, rising health awareness, and demand for advanced diagnostics are driving adoption in countries such as China, India, and Japan. Technological advances, cost-effective solutions, and expanding healthcare access further support regional growth.
Regulatory Landscape
Capsule endoscopy devices are regulated as medical devices. In the United States, the Food and Drug Administration ensures the safety, efficacy, and security of these products, which must receive clearance or approval before being marketed. In the European Union, devices must obtain a CE mark, confirming compliance with safety, health, and environmental protection requirements. These frameworks maintain quality standards but also shape development timelines and market entry strategies for manufacturers.
Competitive Landscape
Companies are concentrating on patient convenience and diagnostic accuracy through innovative, user-friendly systems. Strategies include remote ingestion capabilities, improved image quality, streamlined workflows to reduce patient discomfort, and telehealth-enabled models that reduce the need for in-person visits.
Leading participants named in the report are CapsoVision, Inc., Shangxian Minimal Invasive Inc, INTROMEDIC, Medtronic, Olympus America, AnX Robotics, JINSHAN Science & Technology (Group) Co., Ltd, Check-Cap, RF Co., Ltd., BioCam, Motilis Medica SA, and STERIS.
Recent Developments
Several regulatory approvals in the past two years highlight the pace of innovation. In January 2025, CapsoVision’s CapsoCam Plus system received FDA clearance for remote ingestion, enabling home-based procedures and removing the need for an in-person clinic visit while preserving diagnostic quality. In the same month, CapsoVision also received FDA clearance for pediatric use of its system, allowing young patients to undergo comfortable, non-invasive procedures.
In January 2024, AnX Robotica received FDA clearance for expanded indications of its NaviCam Small Bowel Video Capsule Endoscopy system. The system is now available for adults and children aged two years and above, and it introduces new visualization tools that improve diagnostic capabilities.
Strategic Opportunities for Stakeholders
The report points to several practical opportunities. Manufacturers can differentiate through remote ingestion kits, pediatric indications, and software that speeds image review, since each of these removes friction for clinicians and patients. Diagnostic laboratories, the fastest-growing end-user group at 7.75%, are positioned to benefit as outsourced reading and centralized analysis become more common. In Asia Pacific, where growth is forecast at 8.50%, partnerships with local distributors and hospital networks can accelerate access in China, India, and Japan. Providers that combine telehealth with capsule procedures can also extend gastrointestinal diagnostics to rural and underserved communities, as the Guam example shows.
Outlook
The outlook for capsule endoscopy is positive. Rising gastrointestinal disease burden, patient preference for comfortable procedures, expanding pediatric indications, and the maturing of remote ingestion and telehealth workflows all point toward wider use through 2031. Asia Pacific offers the fastest growth, while North America will remain the largest revenue base. Manufacturers that combine strong imaging performance with simple, remote-ready workflows and robust safety features are best placed to capture the opportunity. For hospitals, diagnostic laboratories, specialty clinics, investors, and device makers, the report offers a detailed view of where demand is building.
About Kings Research: Kings Research is a market research and consulting firm that delivers syndicated reports and customized insights across industries to help organizations make informed strategic decisions.
